Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 26 | 2023 | 3177 | 2.300 |
Why?
|
Kidney Neoplasms | 25 | 2023 | 4274 | 2.010 |
Why?
|
Diagnostic Imaging | 33 | 2019 | 3502 | 1.740 |
Why?
|
Molecular Targeted Therapy | 24 | 2018 | 2782 | 1.680 |
Why?
|
Neoplasm Metastasis | 18 | 2019 | 4861 | 0.830 |
Why?
|
Tomography, X-Ray Computed | 41 | 2023 | 20348 | 0.820 |
Why?
|
Angiogenesis Inhibitors | 8 | 2017 | 2036 | 0.810 |
Why?
|
Radiology | 9 | 2022 | 2090 | 0.790 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2018 | 3468 | 0.780 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 131 | 0.630 |
Why?
|
Muscle Neoplasms | 1 | 2017 | 131 | 0.550 |
Why?
|
Gastrointestinal Stromal Tumors | 8 | 2015 | 612 | 0.540 |
Why?
|
Neoplasms | 19 | 2017 | 21808 | 0.510 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 304 | 0.470 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2017 | 2252 | 0.450 |
Why?
|
Gastrointestinal Neoplasms | 7 | 2015 | 950 | 0.450 |
Why?
|
Soft Tissue Neoplasms | 5 | 2015 | 1149 | 0.430 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3585 | 0.420 |
Why?
|
Antineoplastic Agents | 18 | 2018 | 13553 | 0.420 |
Why?
|
Medical Oncology | 3 | 2019 | 2283 | 0.400 |
Why?
|
Vinblastine | 2 | 2014 | 487 | 0.380 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1201 | 0.380 |
Why?
|
Positron-Emission Tomography | 18 | 2016 | 6413 | 0.370 |
Why?
|
Charcot-Marie-Tooth Disease | 4 | 2008 | 95 | 0.370 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 2322 | 0.370 |
Why?
|
Urothelium | 1 | 2011 | 276 | 0.340 |
Why?
|
Neoplasm Staging | 15 | 2018 | 11064 | 0.340 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1099 | 0.320 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2014 | 798 | 0.320 |
Why?
|
Thromboembolism | 1 | 2014 | 997 | 0.300 |
Why?
|
Colonic Diseases | 1 | 2009 | 198 | 0.300 |
Why?
|
Oncology Service, Hospital | 3 | 2017 | 56 | 0.300 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9101 | 0.290 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1627 | 0.280 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2016 | 1994 | 0.280 |
Why?
|
Radiopharmaceuticals | 11 | 2015 | 2652 | 0.270 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2015 | 1993 | 0.270 |
Why?
|
Benzamides | 5 | 2015 | 1364 | 0.270 |
Why?
|
Endosonography | 2 | 2015 | 605 | 0.270 |
Why?
|
Humans | 122 | 2023 | 752341 | 0.260 |
Why?
|
Bone Neoplasms | 6 | 2018 | 2511 | 0.260 |
Why?
|
Curriculum | 2 | 2017 | 3653 | 0.250 |
Why?
|
Liver Diseases | 1 | 2014 | 1276 | 0.250 |
Why?
|
Vascular Diseases | 1 | 2014 | 1177 | 0.250 |
Why?
|
Magnetic Resonance Imaging | 21 | 2017 | 35916 | 0.250 |
Why?
|
Tumor Burden | 1 | 2011 | 1875 | 0.250 |
Why?
|
Skin Neoplasms | 4 | 2021 | 5726 | 0.240 |
Why?
|
Genomics | 2 | 2019 | 5727 | 0.230 |
Why?
|
Sarcoma | 5 | 2016 | 1788 | 0.220 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2016 | 2064 | 0.220 |
Why?
|
Diagnosis, Differential | 17 | 2017 | 12898 | 0.220 |
Why?
|
Liver Neoplasms | 7 | 2017 | 4271 | 0.220 |
Why?
|
Fibromatosis, Aggressive | 2 | 2016 | 124 | 0.210 |
Why?
|
Treatment Outcome | 26 | 2018 | 64245 | 0.210 |
Why?
|
Hemorrhage | 1 | 2014 | 3568 | 0.210 |
Why?
|
Ultrasonography | 3 | 2014 | 5918 | 0.200 |
Why?
|
Pyrimidines | 7 | 2018 | 2978 | 0.200 |
Why?
|
Piperazines | 5 | 2015 | 2486 | 0.190 |
Why?
|
Neuroendocrine Tumors | 3 | 2018 | 647 | 0.190 |
Why?
|
Aged | 49 | 2021 | 166562 | 0.190 |
Why?
|
Aged, 80 and over | 27 | 2021 | 58300 | 0.180 |
Why?
|
Middle Aged | 51 | 2021 | 217019 | 0.180 |
Why?
|
Thrombosis | 1 | 2015 | 3018 | 0.180 |
Why?
|
Pyrroles | 3 | 2013 | 1131 | 0.180 |
Why?
|
von Hippel-Lindau Disease | 1 | 2021 | 149 | 0.180 |
Why?
|
ROC Curve | 3 | 2014 | 3530 | 0.180 |
Why?
|
Hematologic Neoplasms | 5 | 2016 | 1864 | 0.180 |
Why?
|
Niacinamide | 2 | 2013 | 410 | 0.180 |
Why?
|
Lymphoma | 4 | 2014 | 1887 | 0.170 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1145 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2018 | 5594 | 0.170 |
Why?
|
Teratoma | 2 | 2014 | 401 | 0.170 |
Why?
|
Female | 62 | 2022 | 386053 | 0.170 |
Why?
|
Male | 61 | 2022 | 354881 | 0.170 |
Why?
|
Carcinoid Tumor | 1 | 2021 | 227 | 0.170 |
Why?
|
Esophageal Neoplasms | 3 | 2015 | 1640 | 0.170 |
Why?
|
Phenylurea Compounds | 2 | 2013 | 523 | 0.160 |
Why?
|
Observer Variation | 4 | 2013 | 2579 | 0.160 |
Why?
|
Indoles | 3 | 2013 | 1815 | 0.160 |
Why?
|
Edema | 4 | 2015 | 771 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2016 | 9207 | 0.150 |
Why?
|
Urogenital Neoplasms | 1 | 2019 | 135 | 0.150 |
Why?
|
Contrast Media | 14 | 2017 | 5276 | 0.150 |
Why?
|
Radium | 1 | 2018 | 72 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2015 | 4004 | 0.150 |
Why?
|
Adult | 40 | 2021 | 216913 | 0.150 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2017 | 29 | 0.150 |
Why?
|
Adenoma, Liver Cell | 1 | 2017 | 32 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5163 | 0.140 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 44 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2012 | 732 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 2172 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 157 | 0.140 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6781 | 0.130 |
Why?
|
Pneumatosis Cystoides Intestinalis | 2 | 2012 | 31 | 0.130 |
Why?
|
Osteosarcoma | 2 | 2012 | 888 | 0.130 |
Why?
|
Kidney | 1 | 2011 | 6983 | 0.130 |
Why?
|
Intestinal Fistula | 2 | 2013 | 142 | 0.130 |
Why?
|
Nerve Degeneration | 1 | 2000 | 741 | 0.130 |
Why?
|
Pancreatitis | 2 | 2013 | 1098 | 0.130 |
Why?
|
Prognosis | 13 | 2017 | 29327 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 2269 | 0.130 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2017 | 124 | 0.130 |
Why?
|
Cholecystitis | 2 | 2013 | 182 | 0.120 |
Why?
|
Hormone Antagonists | 1 | 2015 | 108 | 0.120 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 167 | 0.120 |
Why?
|
Retrospective Studies | 22 | 2022 | 79127 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 345 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 211 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 2017 | 362 | 0.120 |
Why?
|
Neoadjuvant Therapy | 3 | 2014 | 2789 | 0.120 |
Why?
|
Intestinal Perforation | 2 | 2012 | 252 | 0.110 |
Why?
|
Neural Conduction | 3 | 2008 | 440 | 0.110 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2015 | 230 | 0.110 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5288 | 0.110 |
Why?
|
Phlebography | 1 | 2015 | 325 | 0.110 |
Why?
|
Vena Cava, Inferior | 2 | 2017 | 456 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2821 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1821 | 0.110 |
Why?
|
Protective Agents | 1 | 2014 | 151 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2715 | 0.110 |
Why?
|
Peripheral Nerves | 2 | 2008 | 466 | 0.110 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 137 | 0.100 |
Why?
|
Rhabdomyoma | 1 | 2012 | 54 | 0.100 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 52 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 6501 | 0.100 |
Why?
|
Histiocytic Sarcoma | 1 | 2012 | 40 | 0.100 |
Why?
|
Axons | 1 | 2000 | 1666 | 0.100 |
Why?
|
Intestine, Small | 2 | 2015 | 1192 | 0.100 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2013 | 100 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 405 | 0.100 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2011 | 44 | 0.100 |
Why?
|
Histiocytosis, Sinus | 1 | 2011 | 44 | 0.100 |
Why?
|
Drug Therapy | 1 | 2014 | 499 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 620 | 0.100 |
Why?
|
Splenic Neoplasms | 1 | 2011 | 96 | 0.100 |
Why?
|
Problem Solving | 1 | 2014 | 436 | 0.090 |
Why?
|
Hormones | 1 | 2015 | 872 | 0.090 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 165 | 0.090 |
Why?
|
Sarcoma, Synovial | 1 | 2012 | 150 | 0.090 |
Why?
|
Hepatitis | 1 | 2013 | 231 | 0.090 |
Why?
|
Vulvar Neoplasms | 1 | 2013 | 264 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 140 | 0.090 |
Why?
|
Radiography | 7 | 2015 | 6964 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2018 | 11586 | 0.090 |
Why?
|
Veins | 1 | 2015 | 765 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 782 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 914 | 0.090 |
Why?
|
Thoracic Wall | 1 | 2012 | 199 | 0.090 |
Why?
|
Benzenesulfonates | 1 | 2011 | 164 | 0.090 |
Why?
|
Peritoneal Neoplasms | 2 | 2015 | 700 | 0.090 |
Why?
|
Pheochromocytoma | 1 | 2012 | 326 | 0.090 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13165 | 0.090 |
Why?
|
Thoracic Neoplasms | 1 | 2012 | 267 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2592 | 0.090 |
Why?
|
Sacrum | 1 | 2011 | 280 | 0.090 |
Why?
|
Enteritis | 1 | 2011 | 160 | 0.090 |
Why?
|
Pathology, Molecular | 1 | 2013 | 331 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2012 | 356 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 298 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6306 | 0.080 |
Why?
|
Anus Neoplasms | 1 | 2013 | 327 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 555 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2011 | 415 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2441 | 0.080 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2012 | 327 | 0.080 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2013 | 319 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 959 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 532 | 0.080 |
Why?
|
Cystectomy | 1 | 2014 | 695 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 492 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 826 | 0.080 |
Why?
|
Liposarcoma | 1 | 2011 | 280 | 0.080 |
Why?
|
Chordoma | 1 | 2011 | 348 | 0.080 |
Why?
|
Electrodiagnosis | 2 | 2008 | 148 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5550 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 518 | 0.080 |
Why?
|
Melanoma | 3 | 2017 | 5620 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2014 | 795 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 923 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1517 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2012 | 503 | 0.070 |
Why?
|
Colitis | 2 | 2013 | 1219 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 562 | 0.070 |
Why?
|
Spinal Neoplasms | 1 | 2014 | 713 | 0.070 |
Why?
|
Urologic Neoplasms | 1 | 2011 | 321 | 0.070 |
Why?
|
Sirolimus | 2 | 2012 | 1534 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 587 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 905 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1519 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1398 | 0.070 |
Why?
|
Internship and Residency | 1 | 2007 | 5812 | 0.070 |
Why?
|
Gait Disorders, Neurologic | 1 | 2009 | 233 | 0.070 |
Why?
|
Image Enhancement | 2 | 2017 | 2887 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3325 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2013 | 19894 | 0.070 |
Why?
|
Lymphatic Metastasis | 4 | 2015 | 2924 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2796 | 0.060 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 545 | 0.060 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 599 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2012 | 935 | 0.060 |
Why?
|
Decision Trees | 2 | 2017 | 504 | 0.060 |
Why?
|
Amyloidosis | 1 | 2012 | 807 | 0.060 |
Why?
|
Connexins | 1 | 2007 | 351 | 0.060 |
Why?
|
Neutrophils | 1 | 2018 | 3724 | 0.060 |
Why?
|
Pyridines | 2 | 2021 | 2861 | 0.060 |
Why?
|
Survival Analysis | 4 | 2019 | 10177 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2014 | 3489 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5481 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 610 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15130 | 0.060 |
Why?
|
Indazoles | 2 | 2018 | 293 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3560 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1359 | 0.060 |
Why?
|
Education, Medical | 1 | 2015 | 1713 | 0.060 |
Why?
|
Time Factors | 4 | 2015 | 39854 | 0.060 |
Why?
|
Ascites | 2 | 2015 | 338 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2012 | 1444 | 0.050 |
Why?
|
Pericardial Effusion | 2 | 2015 | 244 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2309 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1692 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 13900 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8892 | 0.050 |
Why?
|
Boston | 2 | 2016 | 9236 | 0.050 |
Why?
|
Pleural Effusion | 2 | 2015 | 336 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14586 | 0.050 |
Why?
|
Disability Evaluation | 2 | 2008 | 1800 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2340 | 0.050 |
Why?
|
Phenotype | 3 | 2021 | 16439 | 0.050 |
Why?
|
Action Potentials | 3 | 2008 | 1774 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17648 | 0.050 |
Why?
|
Gene Silencing | 1 | 2007 | 1514 | 0.040 |
Why?
|
Pneumonia | 1 | 2012 | 2121 | 0.040 |
Why?
|
Isometric Contraction | 1 | 2000 | 141 | 0.040 |
Why?
|
Urogenital System | 1 | 2019 | 88 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 620 | 0.040 |
Why?
|
Fluorine Radioisotopes | 2 | 2012 | 448 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 380 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 407 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 1978 | 0.040 |
Why?
|
Disease Progression | 5 | 2012 | 13402 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 8931 | 0.040 |
Why?
|
Young Adult | 8 | 2018 | 57629 | 0.040 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 879 | 0.040 |
Why?
|
Colorectal Neoplasms | 2 | 2015 | 6793 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2000 | 496 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 3934 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2515 | 0.040 |
Why?
|
Incidental Findings | 2 | 2012 | 689 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5207 | 0.040 |
Why?
|
Electrophysiology | 1 | 2000 | 1264 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2000 | 410 | 0.040 |
Why?
|
Radioisotopes | 1 | 2018 | 497 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 382 | 0.030 |
Why?
|
Mutation | 3 | 2019 | 29705 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2002 | 1151 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2002 | 4877 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5110 | 0.030 |
Why?
|
Sulfonamides | 2 | 2018 | 1963 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 543 | 0.030 |
Why?
|
United States | 3 | 2018 | 71442 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 124 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2000 | 781 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2018 | 580 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4808 | 0.030 |
Why?
|
Filgrastim | 1 | 2014 | 128 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 419 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 823 | 0.030 |
Why?
|
Mesenchymoma | 1 | 2014 | 48 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 40984 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4573 | 0.030 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 100 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8538 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2008 | 910 | 0.030 |
Why?
|
Movement | 1 | 2000 | 1469 | 0.030 |
Why?
|
Walking | 1 | 2000 | 1173 | 0.030 |
Why?
|
Cholecystitis, Acute | 1 | 2013 | 75 | 0.030 |
Why?
|
World Health Organization | 1 | 2018 | 1294 | 0.030 |
Why?
|
Acute Disease | 2 | 2013 | 7211 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7734 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 548 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1090 | 0.030 |
Why?
|
Fibromatosis, Abdominal | 1 | 2011 | 21 | 0.030 |
Why?
|
Renal Veins | 1 | 2012 | 102 | 0.030 |
Why?
|
Gallbladder | 1 | 2013 | 306 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 662 | 0.020 |
Why?
|
Pancreas | 1 | 2018 | 1676 | 0.020 |
Why?
|
Viscera | 1 | 2012 | 138 | 0.020 |
Why?
|
Sclerosis | 1 | 2012 | 211 | 0.020 |
Why?
|
Carcinosarcoma | 1 | 2012 | 106 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2013 | 405 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2012 | 2410 | 0.020 |
Why?
|
Endonucleases | 1 | 2014 | 370 | 0.020 |
Why?
|
Buttocks | 1 | 2011 | 111 | 0.020 |
Why?
|
Echocardiography | 2 | 2015 | 4950 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2017 | 990 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1741 | 0.020 |
Why?
|
Joints | 1 | 2012 | 322 | 0.020 |
Why?
|
Gastroenteritis | 1 | 2012 | 239 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2012 | 347 | 0.020 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2011 | 126 | 0.020 |
Why?
|
Ovariectomy | 1 | 2012 | 610 | 0.020 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2012 | 239 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1600 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11007 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7995 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2367 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12455 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 720 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11266 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1179 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2013 | 574 | 0.020 |
Why?
|
Leiomyosarcoma | 1 | 2012 | 426 | 0.020 |
Why?
|
Esophagectomy | 1 | 2012 | 466 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1643 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2009 | 155 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 947 | 0.020 |
Why?
|
Adolescent | 5 | 2012 | 86765 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1616 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1702 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2192 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 6955 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1067 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1178 | 0.020 |
Why?
|
Medical Records | 1 | 2012 | 1402 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2842 | 0.020 |
Why?
|
Prednisone | 1 | 2011 | 1562 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1970 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1412 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 167 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 896 | 0.020 |
Why?
|
Nephrectomy | 1 | 2012 | 1000 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1828 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 753 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2916 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4880 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10797 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2635 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2550 | 0.020 |
Why?
|
Ulnar Nerve | 1 | 2005 | 102 | 0.020 |
Why?
|
Ischemia | 1 | 2013 | 1874 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 851 | 0.020 |
Why?
|
Child | 4 | 2012 | 78998 | 0.020 |
Why?
|
Median Nerve | 1 | 2005 | 130 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6509 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1051 | 0.010 |
Why?
|
Aging | 1 | 2002 | 8578 | 0.010 |
Why?
|
Outpatients | 1 | 2011 | 1575 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2011 | 1657 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2290 | 0.010 |
Why?
|
Child, Preschool | 2 | 2008 | 41659 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6743 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8505 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3573 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2146 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2883 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7426 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12746 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39079 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1395 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3379 | 0.010 |
Why?
|
Hindlimb | 1 | 2002 | 506 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3395 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1757 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4648 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4067 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6689 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12137 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4374 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5858 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53807 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2247 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9551 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 73412 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4601 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7399 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14325 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11422 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4631 | 0.010 |
Why?
|
Lung | 1 | 2012 | 9898 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23233 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21158 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10690 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4606 | 0.010 |
Why?
|
Heart Failure | 1 | 2015 | 11725 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12869 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18297 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20843 | 0.010 |
Why?
|
Brain | 1 | 2012 | 26655 | 0.000 |
Why?
|
Mice | 1 | 2002 | 80543 | 0.000 |
Why?
|
Animals | 1 | 2002 | 166802 | 0.000 |
Why?
|